DUBAI, United Arab Emirates, Feb. 10, 2026 (GLOBE NEWSWIRE) -- ...
Tolebrutinib failed to lower disability progression risk in primary progressive MS in a Phase 3 trial, with data shown at ...
Reports that the development contract for the ACMA would be awarded to private players should be welcome except that there are some serious professional issues that need to be thought through ...
Vancouver, British Columbia-- (Newsfile Corp. - February 10, 2026) - Homeland Uranium Corp. (TSXV: HLU) (OTCQB: HLUCF) (FSE: D3U) (" Homeland " or the " Company ") reports the completion of its Phase ...
VANCOUVER, BC / ACCESS Newswire / February 10, 2026 / Apex Critical Metals Corp. (CSE:APXC)(OTCQX:APXCF)(FWB:KL9) ("Apex" or the "Company"), a Canadian mineral exploration company focused on the ident ...
Like a doctor spotting a worrying test result during a routine exam, Gemini’s Plex check had unearthed a critical system ...
VANCOUVER, BC / ACCESS Newswire / February 10, 2026 / Apex Critical Metals Corp. (CSE:APXC)(OTCQX:APXCF)(FWB:KL9) ("Apex" or the "Company"), a ...
Opinion
From Bangladesh to Nepal, US to Israel: Elections that New Delhi will be closely watching in 2026
From disputed ballots and snap elections to historic landslides and democratic pushback against extremism, 2026 is shaping up as a year of political reckoning ...
AstraZeneca will push the pill, elecoglipron, into a comprehensive late-stage program that will test the drug as a ...
Cyprus Mail on MSN
Top 3 cryptos that could shock the market in 2026
s 2026 progresses, market attention has shifted to three tokens: Ripple’s XRP, Binance Coin (BNB), and Mutuum Finance (MUTM). The biggest surprises often come from projects still early in their growth ...
ABP News on MSN
Sagittarius horoscope tomorrow, February 11, 2026: New responsibilities test patience
Sagittarius Horoscope: Hello, adventurous Sagittarius! Your boundless optimism, love for exploration, and thirst for knowledge make you the eternal seeker of the zodiac. Sagittarius isn’t afraid to ...
A Phase 3 clinical trial testing SGT-003, a gene therapy candidate for Duchenne muscular dystrophy (DMD), will start dosing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results